Monovisc Injectable Intra-Articular Device
PMA P090031
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP090031 | Date25 Feb 2014 | StatusActive |
Official records
- FDA PMA database P090031
From the FDA record
FDA PMA P090031
- Received by the FDA
- 29 Dec 2009
- FDA decision
- 25 Feb 2014
- FDA review time
- 1,519 days from receipt to decision
- Docket number
- 14M-0254
APPROVAL FOR THE MONOVISC INJECTABLE INTRA-ARTICULAR DEVICE. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TOCONSERVATIVE NON-PHARMACOLOGIC THERAPY AND TO SIMPLE ANALGESICS (E.G., ACETAMINOPHEN).
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Monovisc
- Generic name
- Acid, hyaluronic, intraarticular
- PMA number
- FDA product code
- MOZ
- Device class
- Class III
- Advisory committee
- Orthopedic
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Monovisc Injectable Intra-Articular Device is a hyaluronic acid-based viscosupplement classified as an intraarticular acid. It is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have not responded adequately to conservative non-pharmacologic therapy and simple analgesics.
This device is supplied as a single-use, sterile injectable solution for intra-articular administration. It is intended for use in clinical settings by healthcare professionals and has received FDA PMA approval under PMA number P090031. The device is available in a 4ml formulation containing 88mg of hyaluronic acid, with multiple registration numbers for tracking and distribution.
Devices cleared under P090031
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Monovisc | N/A | 05065026658029 | — | On the market |
| Monovisc | None | 05060548950033 | — | On the market |
| Monovisc | None | 05060459970090 | — | On the market |
| MONOVISC 277515 | 277515 | 08437027710018 | — | On the market |
| Monovisc 690-016 | 690-016 | 10886705025183 | — | On the market |
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Supartz by Seikagaku Corp.
- Gel-One by Seikagaku Corp.
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Hyalgan Acid, Hyaluronic, Intraarticular by Fidia Farmaceutici S.p.A.
- Euflexxa (1% Sodium Hyaluronate) by Ferring Pharmaceuticals, Inc.
- Durolane by BIOVENTUS LLC
- Gel-Syn Acid, Hyaluronic, Intraarticular by Ibsa Institut Biochimique SA